SGH
DGX icon

Sivik Global Healthcare’s Quest Diagnostics DGX Stock Holding History

Sivik Global Healthcare’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-50,000
Closed -$33K – 68
2014
Q3 		$33K Buy
+50,000
New +$3.08M 0.02% 68

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sivik Global Healthcare's DGX Position: Q4 2025 in Review

Sivik Global Healthcare sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 20,000 shares — an estimated $3.81M sold.

Sivik Global Healthcare first reported a position in DGX in Q1 2014 and held it in 21 quarters. The position peaked at $14.2M in Q2 2020. 1,049 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • Sivik Global Healthcare reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Sivik Global Healthcare sold 20,000 Quest Diagnostics shares in Q4 2025, an estimated $3.81M.
  • Sivik Global Healthcare first reported a position in Quest Diagnostics in Q1 2014 and held it in 21 quarters.
  • Sivik Global Healthcare's Quest Diagnostics position peaked at $14.2M in Q2 2020.
  • 1,049 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Sivik Global Healthcare's 13F filing for Q4 2025, filed 21 Jan 2026.